Hidradenitis Suppurativa Study of Izokibep

Summary

Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin 17A, to which it binds with high affinity. This study investigates izokibep in participants with active Hidradenitis Suppurativa (HS), including tumor necrosis factor-alpha inhibitor (TNFi) naïve participants, and those who had an inadequate response or intolerance to TNFi, or for whom TNFi is contraindicated.

Timeline

Start

2023-06-22

Primary completion

2024-07-24

Completion

2025-01-27

Drugs

Indications